$SNDA

$SNDA Q2 2026 Earnings Preview: Recent $SNDA Insider Trading, Hedge Fund Activity, and More

According to Finnhub, Sanderson Design Group (SNDA) is set to report Q2 2026 earnings on Aug. 10 before market open. Analysts expect revenue of $213.56M and EPS of -$1.18. The article cites Q1 2026 revenue of $122.6M (+33.41% YoY), recent insider purchases, institutional position changes, and a median $40.0 price target.

Original reporting
Published Aug 7, 2026, 9:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 5:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
$SNDA Q2 2026 Earnings Preview: Recent $SNDA Insider Trading, Hedge Fund Activity, and More — source image
Decision brief

The 30-second read

$SNDANeutralMed
01

Why it matters

The primary tradable element is the scheduled earnings release on Aug 10 pre-market with stated consensus revenue and EPS. Secondary signals (insider purchases, institutional adds) may influence positioning but are not definitive without the earnings print.

02

Market read

Traders can use the Aug 10 pre-market earnings date and consensus -$1.18 EPS and $213.56M revenue to size event risk and set expectations for a loss-making quarter.

03

What to watch

The article does not include guidance, margin drivers, cash burn, or segment performance, which are typically the key swing factors for post-earnings repricing.

Relevance 6/10Novelty 5/10Timing: Ahead of Aug 10 pre-market earnings release

Background

Quiver Quantitative frames SNDA’s upcoming Q2 2026 earnings as an event with consensus estimates and supporting flow data (insider trades, institutional holdings, and congressional trades).

Company-level read

Ticker impact

$SNDANeutralMedium confidence
Context

The article previews SNDA’s Q2 2026 earnings release for Aug 10 pre-market and cites consensus revenue of $213.56M and EPS of -$1.18.

Expected impact

Near-term volatility is likely around the Aug 10 pre-market print versus the -$1.18 EPS and $213.56M revenue expectations; direction depends on whether results narrow the loss and/or show revenue acceleration.

Evidence & confidence

The text provides a specific scheduled earnings date and consensus numbers, which are actionable for event-risk positioning. Insider and 13F-style flows are supportive but not a substitute for the earnings datapoint itself.

Market effects

Limited direct sector read-through because the piece is primarily an earnings preview for a single name.

No clear regional spillover beyond US small/mid-cap event risk.

No global macro or cross-border catalyst described.

Counterpoint

Insider and institutional buying can be noisy around earnings, and the consensus still implies negative EPS, so the setup may not be meaningfully bullish.

Key entities

  • SNDA

    Subject of the earnings preview, with consensus revenue and EPS expectations and reported insider/institutional activity.

  • Michael Simanovsky

    Named insider reporting 4 open-market purchases over the past 6 months.

  • BlackRock, Inc.

    Named institutional holder reporting a large share increase in the most recent quarter(s) cited.

Related articles

$DYNMed

Biotech Stocks At 52-Week Highs - LH Rises With Genetic Testing Launch, DYN, SNDA, SLN, AMLX,

Biotech and healthcare stocks hit 52-week highs on July 27, 2026. Dyne Therapeutics (DYN) rose over 5% to $26.12 after FDA accepted its Z-Rostudirsen BLA; it raised $431m. Sonida Senior Living (SNDA) reached $44.38 after its CHP acquisition. Silence Therapeutics (SLN) hit $12.19. Amylyx (AMLX) rose to $19.60. Labcorp (LH) climbed to $301.7 after launching a genetic testing platform; Q1 revenue was $3.54b and 2026 revenue guidance $14.65b-$14.80b.

$SNDAMed

Sunda Energy (LON:SNDA) Sets New 52

Sunda Energy Plc (LON:SNDA) shares hit a new 52-week low on Thursday, trading as low as 1.60p and last at 1.70p versus a prior close of 1.82p, with 2.21m shares traded. The stock was down 11.1%. The company’s market cap is £5.52m, with a negative P/E of -2.00.

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.